Characterisation of the cytokine milieu associated with the up-regulation of IL-6 and suppressor of cytokine 3 in chronic hepatitis C treatment non-responders.
about
Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy.Presence of Systemic Inflammatory Response Syndrome Predicts a Poor Clinical Outcome in Dogs with a Primary Hepatitis.Effects of chronic hepatitis C genotype 1 and 4 on serum activins and follistatin in treatment naïve patients and their correlations with interleukin-6, tumour necrosis factor-α, viral load and liver damage.
P2860
Characterisation of the cytokine milieu associated with the up-regulation of IL-6 and suppressor of cytokine 3 in chronic hepatitis C treatment non-responders.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Characterisation of the cytoki ...... is C treatment non-responders.
@en
Characterisation of the cytoki ...... is C treatment non-responders.
@nl
type
label
Characterisation of the cytoki ...... is C treatment non-responders.
@en
Characterisation of the cytoki ...... is C treatment non-responders.
@nl
prefLabel
Characterisation of the cytoki ...... is C treatment non-responders.
@en
Characterisation of the cytoki ...... is C treatment non-responders.
@nl
P2093
P2860
P50
P356
P1433
P1476
Characterisation of the cytoki ...... is C treatment non-responders.
@en
P2093
Barbara A Cameron
Clovis Palmer
Danica Martinez
Nam Nguyen
Vipul Aggarwal
P2860
P304
P356
10.1111/LIV.12473
P577
2014-02-14T00:00:00Z